- Home
- CVM vs XTNT Comparison
CVM vs XTNT Comparison
Compare CVM & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- XTNT
- Stock Information
- Founded
- CVM 1983
- XTNT N/A
- Country
- CVM United States
- XTNT United States
- Employees
- CVM N/A
- XTNT N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVM Health Care
- XTNT Health Care
- Exchange
- CVM Nasdaq
- XTNT Nasdaq
- Market Cap
- CVM 71.2M
- XTNT 82.1M
- IPO Year
- CVM 1987
- XTNT N/A
- Fundamental
- Price
- CVM $9.91
- XTNT $0.62
- Analyst Decision
- CVM
- XTNT
- Analyst Count
- CVM 0
- XTNT 0
- Target Price
- CVM N/A
- XTNT N/A
- AVG Volume (30 Days)
- CVM 294.7K
- XTNT 60.3K
- Earning Date
- CVM 08-14-2025
- XTNT 11-11-2025
- Dividend Yield
- CVM N/A
- XTNT N/A
- EPS Growth
- CVM N/A
- XTNT N/A
- EPS
- CVM N/A
- XTNT N/A
- Revenue
- CVM N/A
- XTNT $127,766,000.00
- Revenue This Year
- CVM N/A
- XTNT $13.03
- Revenue Next Year
- CVM N/A
- XTNT N/A
- P/E Ratio
- CVM N/A
- XTNT N/A
- Revenue Growth
- CVM N/A
- XTNT 15.16
- 52 Week Low
- CVM $1.98
- XTNT $0.33
- 52 Week High
- CVM $38.70
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- CVM 51.86
- XTNT 51.53
- Support Level
- CVM N/A
- XTNT N/A
- Resistance Level
- CVM $10.48
- XTNT $0.64
- Average True Range (ATR)
- CVM 1.11
- XTNT 0.04
- MACD
- CVM -0.64
- XTNT -0.02
- Stochastic Oscillator
- CVM 73.74
- XTNT 88.87
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.